scispace - formally typeset
E

Eran Schenker

Researcher at Ben-Gurion University of the Negev

Publications -  5
Citations -  916

Eran Schenker is an academic researcher from Ben-Gurion University of the Negev. The author has contributed to research in topics: Infertility & Population. The author has an hindex of 5, co-authored 5 publications receiving 884 citations.

Papers
More filters
Journal ArticleDOI

AMON: a wearable multiparameter medical monitoring and alert system

TL;DR: The AMON system includes continuous collection and evaluation of multiple vital signs, intelligent multiparameter medical emergency detection, and a cellular connection to a medical center, and is validated by a medical study with a set of 33 subjects.
Journal ArticleDOI

Stress and human reproduction.

TL;DR: Infertility causes stress which is aggravated as time passes and the couple remains infertile, among the causes of stress are the couple's isolation, life with unrealized potential and unborn child, disruption of day-to-day life during infertility evaluation and treatment, and theouple's feeling that they do not have control of their own lives.
Patent

Mobile health and life signs detector

Eran Schenker
TL;DR: In this article, a life detector is used to determine whether an organism or part thereof suits a life condition predefined by a set of ranges, each for a physiological parameter and each characterizing this life condition.
Journal ArticleDOI

Did anxiety during the Gulf War cause premature delivery

TL;DR: In this research, the connection between environmental stress and preterm delivery was studied and one thousand twenty-two deliveries during the Persian Gulf War showed no differences in the average gestational age, the rate of premature labor, and the cesarean section rate.
Journal ArticleDOI

Exploration of α1-antitrypsin treatment protocol for islet transplantation: dosing plan and route of administration.

TL;DR: Results indicate that dividing the commonly prescribed 60mg/kg i.p. dose to three 20 mg/kg injections is superior in affording islet graft survival; in addition, a short dynamic descending dose protocol is comparable in outcomes to indefinite 60 mg/ kg injections.